Dana Farber Cancer Institute- Chestnut Hill — Newton, Massachusetts

Dana Farber Cancer Institute- Chestnut Hill is a clinical research site located in Newton, Massachusetts, United States 02467.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute- Chestnut Hill has participated in 25 clinical trials with 20 currently active.

Therapeutic areas: Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma.

Sponsors: National Cancer Institute (NCI), Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newton

Browse all research sites in Massachusetts · View every site in Newton

• Mass General at Newton Wellesley Hospital
• New England Hematology Oncology/Massachusetts General Cancer Center at Newton Wellesley Hospital
• Mass General Cancer Center at Newton-Wellesley Hospital's Vernon Cancer Center
• Newton-Wellelsey Hospital
• Tufts University School of Medicine
• Mass General Cancer Center Newton-Wellesley Hospital
• Brigham & Women's Hospital
• Newton Wesley Hospital
• Newton-Wellesley Hospital- Ambulatory Pain Service
• Massachusetts General Hospital at Newton-Wellesley Hospital
• Newton Wellesley Hospital Ambulatory Care Center
• Kaplan Joint Center, Newton Wellesley Hospital

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute- Chestnut Hill?

Dana Farber Cancer Institute- Chestnut Hill has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute- Chestnut Hill conducted?

Dana Farber Cancer Institute- Chestnut Hill has 25 clinical trials on record, with 20 currently active. Their work covers Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma.

Is Dana Farber Cancer Institute- Chestnut Hill accredited by Crixeo Clinical Trials?

Dana Farber Cancer Institute- Chestnut Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute- Chestnut Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.